The impact of patient characteristics on enzalutamide pharmacokinetics and how this relates to treatment toxicity and efficacy in metastatic prostate cancer patients

Por Benoist, Guillemette E., van Oort, Inge M., Burger, David M., Mehra, Niven, van Erp, Nielka P.
Publicado no Cancer Chemother Pharmacol (2020)

Prognostic relevance of number and bilaterality of positive surgical margins after radical prostatectomy

Por Somford, Diederik M., van Oort, Inge M., Cosyns, Jean-Pierre, Witjes, J. Alfred, Kiemeney, Lambertus A. L. M., Tombal, Bertrand
Publicado em 2011

PREDICT: model for prediction of survival in localized prostate cancer

Por Kerkmeijer, Linda G. W., Monninkhof, Evelyn M., van Oort, Inge M., van der Poel, Henk G., de Meerleer, Gert, van Vulpen, Marco
Publicado no World J Urol (2015)

Known susceptibility SNPs for sporadic prostate cancer show a similar association with “hereditary” prostate cancer

Por Cremers, Ruben G., Galesloot, Tessel E., Aben, Katja K., van Oort, Inge M., Vasen, Hans F., Vermeulen, Sita H., Kiemeney, Lambertus A.
Publicado no Prostate (2015)

The clinical phenotype of hereditary versus sporadic prostate cancer: HPC definition revisited

Por Cremers, Ruben G., Aben, Katja K., van Oort, Inge M., Sedelaar, J.P. Michiel, Vasen, Hans F., Vermeulen, Sita H., Kiemeney, Lambertus A.
Publicado no Prostate (2016)

Drug–drug interaction potential in men treated with enzalutamide: Mind the gap

Por Benoist, Guillemette Emma, van Oort, Inge M., Smeenk, Stella, Javad, Adrian, Somford, Diederik M., Burger, David M., Mehra, Niven, van Erp, Nielka P.
Publicado no Br J Clin Pharmacol (2017)

Development and validation of a bioanalytical method to quantitate enzalutamide and its active metabolite N-desmethylenzalutamide in human plasma: application to clinical managemen...

Por Benoist, Guillemette E, van der Meulen, Eric, van Oort, Inge M, Beumer, Jan Hendrik, Somford, Diederik M, Schalken, Jack A, Burger, David M, van Erp, Nielka P
Publicado no Ther Drug Monit (2018)

Epigenetic markers in circulating cell‐free DNA as prognostic markers for survival of castration‐resistant prostate cancer patients

Por Hendriks, Rianne J., Dijkstra, Siebren, Smit, Frank P., Vandersmissen, Johan, Van de Voorde, Hendrik, Mulders, Peter F. A., van Oort, Inge M., Van Criekinge, Wim, Schalken, Jack A.
Publicado no Prostate (2018)

Value of PCA3 to Predict Biopsy Outcome and Its Potential Role in Selecting Patients for Multiparametric MRI

Por Leyten, Gisele H. J. M., Wierenga, Elisabeth A., Michiel Sedelaar, J. P., van Oort, Inge M., Futterer, Jurgen J., Barentsz, Jelle O., Schalken, Jack A., Mulders, Peter F. A.
Publicado em 2013

Does a decision aid for prostate cancer affect different aspects of decisional regret, assessed with new regret scales? A randomized, controlled trial

Por van Tol‐Geerdink, Julia J., Leer, Jan Willem H., Wijburg, Carl J., van Oort, Inge M., Vergunst, Henk, van Lin, Emile J., Witjes, J. Alfred, Stalmeier, Peep F. M.
Publicado no Health Expect (2015)

Pharmacokinetic Aspects of the Two Novel Oral Drugs Used for Metastatic Castration-Resistant Prostate Cancer: Abiraterone Acetate and Enzalutamide

Por Benoist, Guillemette E., Hendriks, Rianne J., Mulders, Peter F. A., Gerritsen, Winald R., Somford, Diederik M., Schalken, Jack A., van Oort, Inge M., Burger, David M., van Erp, Nielka P.
Publicado no Clin Pharmacokinet (2016)

Prior PSMA PET-CT Imaging and Hounsfield Unit Impact on Tumor Yield and Success of Molecular Analyses from Bone Biopsies in Metastatic Prostate Cancer

Por Smits, Minke, Ekici, Kamer, Pamidimarri Naga, Samhita, van Oort, Inge M., Sedelaar, Michiel J. P., Schalken, Jack A., Nagarajah, James, Scheenen, Tom W. J., Gerritsen, Winald R., Fütterer, Jurgen J., Mehra, Niven
Publicado no Cancers (Basel) (2020)

High Health-Related Quality of Life During Dendritic Cell Vaccination Therapy in Patients With Castration-Resistant Prostate Cancer

Por Westdorp, Harm, Creemers, Jeroen H. A., van Oort, Inge M., Mehra, Niven, Hins-de Bree, Simone M., Figdor, Carl G., Witjes, J. Alfred, Schreibelt, Gerty, de Vries, I. Jolanda M., Gerritsen, Winald R., Ottevanger, Petronella B.
Publicado no Front Oncol (2020)

Introducing Decision Aids into Routine Prostate Cancer Care in The Netherlands: Implementation and Patient Evaluations from the Multi-regional JIPPA Initiative

Por Cuypers, Maarten, Al-Itejawi, Hoda H. M., van Uden-Kraan, Cornelia F., Stalmeier, Peep F. M., Lamers, Romy E. D., van Oort, Inge M., Somford, Diederik M., van Moorselaar, Reindert Jeroen A., Verdonck-de Leeuw, Irma M., van de Poll-Franse, Lonneke V., van Tol-Geerdink, Julia J., de Vries, Marieke
Publicado no J Cancer Educ (2019)

Impact of DNA damage repair defects and aggressive variant features on response to carboplatin‐based chemotherapy in metastatic castration‐resistant prostate cancer

Por Slootbeek, Peter H. J., Duizer, Marleen L., van der Doelen, Maarten J., Kloots, Iris S. H., Kuppen, Malou C. P., Westgeest, Hans M., Uyl‐de Groot, Carin A., Pamidimarri Naga, Samhita, Ligtenberg, Marjolijn J. L., van Oort, Inge M., Gerritsen, Winald R., Schalken, Jack A., Kroeze, Leonie I., Bloemendal, Haiko J., Mehra, Niven
Publicado no Int J Cancer (2020)

Blood-derived dendritic cell vaccinations induce immune responses that correlate with clinical outcome in patients with chemo-naive castration-resistant prostate cancer

Por Westdorp, Harm, Creemers, Jeroen H. A., van Oort, Inge M., Schreibelt, Gerty, Gorris, Mark A. J., Mehra, Niven, Simons, Michiel, de Goede, Anna L., van Rossum, Michelle M., Croockewit, Alexandra J., Figdor, Carl G., Witjes, J. Alfred, Aarntzen, Erik H. J. G., Mus, Roel D. M., Brüning, Mareke, Petry, Katja, Gotthardt, Martin, Barentsz, Jelle O., de Vries, I. Jolanda M., Gerritsen, Winald R.
Publicado no J Immunother Cancer (2019)

The genomic landscape of metastatic castration-resistant prostate cancers reveals multiple distinct genotypes with potential clinical impact

Por van Dessel, Lisanne F., van Riet, Job, Smits, Minke, Zhu, Yanyun, Hamberg, Paul, van der Heijden, Michiel S., Bergman, Andries M., van Oort, Inge M., de Wit, Ronald, Voest, Emile E., Steeghs, Neeltje, Yamaguchi, Takafumi N., Livingstone, Julie, Boutros, Paul C., Martens, John W. M., Sleijfer, Stefan, Cuppen, Edwin, Zwart, Wilbert, van de Werken, Harmen J. G., Mehra, Niven, Lolkema, Martijn P.
Publicado no Nat Commun (2019)

Lutetium-177-PSMA-I&T as metastases directed therapy in oligometastatic hormone sensitive prostate cancer, a randomized controlled trial

Por Privé, Bastiaan M., Janssen, Marcel J. R., van Oort, Inge M., Muselaers, Constantijn H. J., Jonker, Marianne A., de Groot, Michel, Mehra, Niven, Verzijlbergen, J. Fred, Scheenen, Tom W. J., Zámecnik, Patrik, Barentsz, Jelle O., Gotthardt, Martin, Noordzij, Walter, Vogel, Wouter V., Bergman, Andries M., van der Poel, Henk G., Vis, André N., Oprea-Lager, Daniela E., Gerritsen, Winald R., Witjes, J. Alfred, Nagarajah, James
Publicado no BMC Cancer (2020)

Genome-wide association and replication studies identify four variants associated with prostate cancer susceptibility

Por Gudmundsson, Julius, Sulem, Patrick, Gudbjartsson, Daniel F., Blondal, Thorarinn, Gylfason, Arnaldur, Agnarsson, Bjarni A., Benediktsdottir, Kristrun R., Magnusdottir, Droplaug N., Orlygsdottir, Gudbjorg, Jakobsdottir, Margret, Stacey, Simon N., Sigurdsson, Asgeir, Wahlfors, Tiina, Tammela, Teuvo, Breyer, Joan P., McReynolds, Kate M., Bradley, Kevin M., Saez, Berta, Godino, Javier, Navarrete, Sebastian, Fuertes, Fernando, Murillo, Laura, Polo, Eduardo, Aben, Katja K., van Oort, Inge M., Suarez, Brian K., Helfand, Brian T., Kan, Donghui, Zanon, Carlo, Frigge, Michael L., Kristjansson, Kristleifur, Gulcher, Jeffrey R., Einarsson, Gudmundur V., Jonsson, Eirikur, Catalona, William J., Mayordomo, Jose I., Kiemeney, Lambertus A., Smith, Jeffrey R., Schleutker, Johanna, Barkardottir, Rosa B., Kong, Augustine, Thorsteinsdottir, Unnur, Rafnar, Thorunn, Stefansson, Kari
Publicado em 2009

A study based on whole-genome sequencing yields a rare variant at 8q24 associated with prostate cancer

Por Gudmundsson, Julius, Sulem, Patrick, Gudbjartsson, Daniel F., Masson, Gisli, Agnarsson, Bjarni A., Benediktsdottir, Kristrun R., Sigurdsson, Asgeir, Magnusson, Olafur Th., Gudjonsson, Sigurjon A., Magnusdottir, Droplaug N., Johannsdottir, Hrefna, Helgadottir, Hafdis Th., Stacey, Simon N., Jonasdottir, Adalbjorg, Olafsdottir, Stefania B., Thorleifsson, Gudmar, Jonasson, Jon G., Tryggvadottir, Laufey, Navarrete, Sebastian, Fuertes, Fernando, Helfand, Brian T., Hu, Qiaoyan, Csiki, Irma E., Mates, Ioan N., Jinga, Viorel, Aben, Katja K. H., van Oort, Inge M., Vermeulen, Sita H., Donovan, Jenny L., Hamdy, Freddy C., Ng, Chi-Fai, Chiu, Peter K.F., Lau, Kin-Mang, Ng, Maggie C.Y., Gulcher, Jeffrey R., Kong, Augustine, Catalona, William J., Mayordomo, Jose I., Einarsson, Gudmundur V., Barkardottir, Rosa B., Jonsson, Eirikur, Mates, Dana, Neal, David E., Kiemeney, Lambertus A., Thorsteinsdottir, Unnur, Rafnar, Thorunn, Stefansson, Kari
Publicado em 2012